Ticaspray
NDC Package 69621-392-00

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Ticaspray is a . Marketed by Shoreline Pharmaceuticals, Inc., this product is identified by NDC 69621-392 and is authorized under FDA application ANDA077538.

Identification & Billing

NDC Package Code
69621-392-00
Package Description
1 KIT in 1 KIT * 1 BOTTLE, SPRAY in 1 CARTON (60505-0829-1) / 120 SPRAY, METERED in 1 BOTTLE, SPRAY
Product Code
69621-392
11-Digit Billing Format
69621039200

Clinical Specifications

Proprietary Name
Ticaspray
Dosage Form
-

Regulatory & Marketing

Labeler Name
Shoreline Pharmaceuticals, Inc.
FDA Application #
ANDA077538
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
05-10-2016
End Marketing Date
05-16-2019
Listing Expiration
05-16-2019
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69621-392-00 identifies a specific commercial package of 1 kit in 1 kit * 1 bottle, spray in 1 carton (60505-0829-1) / 120 spray, metered in 1 bottle, spray of Ticaspray, labeled by Shoreline Pharmaceuticals, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Shoreline Pharmaceuticals, Inc. on May 10, 2016. The current certification is valid through May 16, 2019.

How is this Shoreline Pharmaceuticals, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69621039200. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69621-392-00
11-Digit CMS (5-4-2)
69621-0392-00

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.